Key Details of Allotment

  • Allotment Date: October 21, 2026
  • Approving Authority: Nomination and Remuneration Committee of the Company via resolution by circulation
  • Regulatory Reference: SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulation 30) and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (Regulation 10(c))

Share Allotment Details

  • Number of shares allotted: 1,02,000 equity shares
  • Face value: ₹2 per share
  • Exercise price per share: ₹2
  • Premium per share: ₹0 (zero)
  • Total consideration: ₹2,04,000
  • Distinctive numbers: 6,79,04,533 to 6,80,06,532
  • Lock-in period: Not applicable

Capital Structure Impact

  • Pre-allotment capital: Not disclosed
  • Post-allotment paid-up equity share capital: ₹13,60,13,064
  • Post-allotment total equity shares: 6,80,06,532 equity shares of ₹2 each
  • Dilution impact: Approximately 1.50% dilution (102,000 shares against new total of 6,800,532 shares)
  • Share characteristics: New shares rank pari-passu with existing equity shares

ESOP Scheme Background

  • Scheme name: WIL Employee Stock Options Plan 2020
  • Principal approval obtained for: 10,00,000 equity shares
  • BSE approval date: May 29, 2021 (Filing No. 131185)
  • NSE approval date: May 31, 2021 (Filing No. 27139)

Additional Information

  • Share certificates: Not applicable (Demat issuance)
  • Listing fees: No additional fees payable as company's paid-up capital (₹13.60 crore) remains within the ₹100 crore slab for which fees have already been paid